Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective

被引：3

作者：

Friesen, Chance S. ^{[1
]}

Chan, Sherwin S. ^{[2
,3
]}

Wagner, Jonathan B. ^{[2
,3
]}

Hosey-Cojocari, Chelsea ^{[2
]}

Csanaky, Ivan L. ^{[2
,3
,4
]}

Shakhnovich, Valentina ^{[2
,3
,4
,5
]}

机构：

[1] Univ Kansas, Sch Med, Kansas City, MO USA

[2] Childrens Mercy Kansas City, 2401 Gillham Rd, Kansas City, MO 64108 USA

[3] Univ Missouri, Sch Med, Kansas City, MO 64108 USA

[4] Univ Kansas, Med Ctr, Kansas City, MO USA

[5] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA

来源：

CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2021年 / 14卷 / 03期

关键词：

D O I：

10.1111/cts.12952

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Nonalcoholic fatty liver disease (NAFLD) affects up to 70% of children with obesity and has become the number one etiology for liver transplant in the United States. Early, effective intervention is critical to prevent disease progression into adulthood. Yet, it is seldom achieved through lifestyle modification alone. Thus, children must be included in NAFLD pharmacology trials, which, to date, continue to focus primarily on adult populations. This commentary serves as a call to action.

引用

页码：781 / 783

页数：3

共 50 条

[41] Therapeutic options in hypertrophic cardiomyopathy: A pediatric perspective
Rhee E.K.
Nigro J.J.
Pophal S.G.
Current Treatment Options in Cardiovascular Medicine, 2008, 10 (5) : 433 - 441
[42] Asthma in Pediatric Patients: Unmet Need and Therapeutic Options
Maykut, Robert
Zeiger, Robert S.
Brown, Mark A.
CLINICAL PEDIATRICS, 2010, 49 (10) : 915 - 930
[43] Pharmacologic behavior management for pediatric dental treatment
Wilson, S
PEDIATRIC CLINICS OF NORTH AMERICA, 2000, 47 (05) : 1159 - +
[44] Pharmacologic treatment of acute pediatric methamphetamine toxicity
Ruha, Anne-Michelle
Yarema, Mark C.
PEDIATRIC EMERGENCY CARE, 2006, 22 (12) : 782 - 785
[45] Pharmacologic Treatment Options in Mild, Moderate, and Severe Acne Vulgaris
Baldwin, Hilary E.
Zaenglein, Andrea L.
Leyden, James J.
Webster, Guy F.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2015, 34 : S82 - S85
[46] Treatment of COPD exacerbations - Pharmacologic options and modification of risk factors
Blanchard, AR
POSTGRADUATE MEDICINE, 2002, 111 (06) : 65 - +
[47] Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment
Wackernah, Robin C.
Minnick, Matthew J.
Clapp, Peter
SUBSTANCE ABUSE AND REHABILITATION, 2014, 5 : 1 - 12
[48] Pharmacologic Treatment Options for Obesity: What Is Old Is New Again
Ryan, Donna H.
Bray, George A.
CURRENT HYPERTENSION REPORTS, 2013, 15 (03) : 182 - 189
[49] Options for Multiple Food Allergies - Food Avoidance or Pharmacologic Treatment?
Wong, Gary W. K.
NEW ENGLAND JOURNAL OF MEDICINE, 2024,
[50] Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia
Vinogradov, Sophia
Schulz, S. Charles
JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 : 12 - 16

← 1 2 3 4 5 →